{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T07:25:22Z","timestamp":1793258722529,"version":"4.5.0"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2021,12,27]],"date-time":"2021-12-27T00:00:00Z","timestamp":1640563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Canadian Institutes of Health Research (CIHR) and the Institute of Genetics","award":["SBI-167982"],"award-info":[{"award-number":["SBI-167982"]}]},{"name":"Novartis Chair in Medicine at McGill University"},{"DOI":"10.13039\/501100000245","name":"Michael Smith Foundation for Health Research scholar","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Tier II Canada Research Chair in Precision Cardiovascular Disease Prevention"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>Homozygous familial hypercholesterolaemia (HoFH) is a genetic condition characterized by extremely elevated levels of low-density lipoprotein cholesterol and premature atherosclerotic cardiovascular disease and death. Due to its rarity, accurate assessment of cardiovascular outcomes associated with HoFH and how they have changed over time has been challenging. The goal of this study was to assess the prevalence and age-of-onset of major adverse cardiovascular events (MACE) among patients with HoFH.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>We searched MEDLINE, EMBASE, Pubmed, Cochrane Central Register of Controlled Trials, Scopus, Africa-Wide, Google Scholar, Open Grey, and various clinical trial registries from inception to February 2020 to identify studies reporting on MACE in HoFH patients. We determined the pooled prevalence and mean age-of-onset of MACE outcomes individually using a random effects inverse variance model. We identified 94 studies that met our eligibility criteria. Myocardial infarction and coronary revascularization were common with a prevalence of 15.1% [95% confidence interval (95% CI) 10.7\u201320.0] and 28.3% (95% CI 22.5\u201334.3), respectively. The mean age-of-onset was 24.5 (95% CI 19.2\u201329.8) years for myocardial infarction and 32.2 (95% CI 26.6\u201337.8) years for revascularization. Sub-group analyses based on the year of publication revealed significant delays in the onset of MACE outcomes post-1990 compared to pre-1990. Egger\u2019s regression suggested possible bias, likely due to small study effects.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Atherosclerotic cardiovascular disease is common among HoFH patients and occurs at a young age. Age-of-onset of myocardial infarction was delayed by more than a decade from pre-1990 to post-1990, likely attributable to widespread use of statins and other therapies, reflecting substantial progress in the management of this rare but severe disorder.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/eurjpc\/zwab224","type":"journal-article","created":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T20:23:48Z","timestamp":1639513428000},"page":"817-828","source":"Crossref","is-referenced-by-count":30,"title":["Major adverse cardiovascular events in homozygous familial hypercholesterolaemia: a systematic review and meta-analysis"],"prefix":"10.1093","volume":"29","author":[{"given":"Adam I","family":"Kramer","sequence":"first","affiliation":[{"name":"Department of Medicine, University of British Columbia, Vancouver V5Z 1M9, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo E","family":"Akioyamen","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Toronto, Toronto, ON M5S 1A8, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seohyuk","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06510, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"B\u00e9langer","sequence":"additional","affiliation":[{"name":"Research Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Ruel","sequence":"additional","affiliation":[{"name":"Research Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Hales","sequence":"additional","affiliation":[{"name":"McGill University Health Center Medical Libraries, Montreal, QC H3G 1A4, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Genest","sequence":"additional","affiliation":[{"name":"Research Institute of the McGill University Health Centre, Montreal, QC H4A 3J1, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3686-3807","authenticated-orcid":false,"given":"Liam R","family":"Brunham","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of British Columbia, Vancouver V5Z 1M9, Canada"},{"name":"Centre for Heart Lung Innovation, University of British Columbia, 1081 Burrard Street \u2013 Room 166, Vancouver V6Z 1Y6, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,12,27]]},"reference":[{"key":"2022050522132729400_zwab224-B1","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1093\/eurheartj\/ehu274","article-title":"Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society","volume":"35","author":"Cuchel","year":"2014","journal-title":"Eur Heart J"},{"key":"2022050522132729400_zwab224-B2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11883-019-0787-5","article-title":"Current role of lipoprotein apheresis","volume":"21","author":"Thompson","year":"2019","journal-title":"Curr Atheroscler Rep"},{"key":"2022050522132729400_zwab224-B3","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1161\/CIRCULATIONAHA.111.042523","article-title":"Reduction in mortality in subjects with homozygous familial hypercholesterolemia associated with advances in lipid-lowering therapy","volume":"124","author":"Raal","year":"2011","journal-title":"Circulation"},{"key":"2022050522132729400_zwab224-B4","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"2022050522132729400_zwab224-B5","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/0002-9343(64)90196-2","article-title":"The inheritance of essential familial hypercholesterolemia","volume":"37","author":"Khachadurian","year":"1964","journal-title":"Am J Med"},{"key":"2022050522132729400_zwab224-B6","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/jech-2013-203104","article-title":"Meta-analysis of prevalence","volume":"67","author":"Barendregt","year":"2013","journal-title":"J Epidemiol Community Health"},{"key":"2022050522132729400_zwab224-B7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/2049-3258-72-39","article-title":"Metaprop: a Stata command to perform meta-analysis of binomial data","volume":"72","author":"Nyaga","year":"2014","journal-title":"Arch Public Health"},{"key":"2022050522132729400_zwab224-B8","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1136\/bmj.331.7521.903","article-title":"Standard deviations and standard errors","volume":"331","author":"Altman","year":"2005","journal-title":"BMJ"},{"key":"2022050522132729400_zwab224-B9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jclinepi.2005.06.006","article-title":"Imputing missing standard deviations in meta-analyses can provide accurate results","volume":"59","author":"Furukawa","year":"2006","journal-title":"J Clin Epidemiol"},{"key":"2022050522132729400_zwab224-B10","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jclinepi.2006.06.018","article-title":"Imputing variance estimates do not alter the conclusions of a meta-analysis with continuous outcomes: a case study of changes in renal function after living kidney donation","volume":"60","author":"Thiessen Philbrook","year":"2007","journal-title":"J Clin Epidemiol"},{"key":"2022050522132729400_zwab224-B11","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"2022050522132729400_zwab224-B12","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"2022050522132729400_zwab224-B13","first-page":"CD004816","article-title":"Statins for the primary prevention of cardiovascular disease","author":"Taylor","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"2022050522132729400_zwab224-B14","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","year":"2010","journal-title":"Lancet"},{"key":"2022050522132729400_zwab224-B15","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/S0002-9149(98)00692-4","article-title":"Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia. Hokuriku-FH-LDL-Apheresis Study Group","volume":"82","author":"Mabuchi","year":"1998","journal-title":"Am J Cardiol"},{"key":"2022050522132729400_zwab224-B16","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s00467-018-3906-6","article-title":"Multimodal lipid-lowering treatment in pediatric patients with homozygous familial hypercholesterolemia-target attainment requires further increase of intensity","volume":"33","author":"Klaus","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"2022050522132729400_zwab224-B17","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.atherosclerosis.2017.01.002","article-title":"Homozygous familial hypercholesterolemia: summarized case reports","volume":"257","author":"Widhalm","year":"2017","journal-title":"Atherosclerosis"},{"key":"2022050522132729400_zwab224-B18","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/jamacardio.2019.5173","article-title":"Reducing the clinical and public health burden of familial hypercholesterolemia: a global call to action","volume":"5","author":"Wilemon","year":"2020","journal-title":"JAMA Cardiol"},{"key":"2022050522132729400_zwab224-B19","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.amjcard.2020.12.080","article-title":"Supravalvular aortic stenosis and the risk of premature death among patients with homozygous familial hypercholesterolemia","volume":"145","author":"Zhang","year":"2021","journal-title":"Am J Cardiol"},{"key":"2022050522132729400_zwab224-B20","first-page":"2508","article-title":"Phenotypical, clinical, and molecular aspects of adults and children with homozygous familial hypercholesterolemia in iberoamerica","volume":"40","author":"Alves","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022050522132729400_zwab224-B21","doi-asserted-by":"crossref","first-page":"g7873","DOI":"10.1136\/bmj.g7873","article-title":"High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study","volume":"350","author":"Shah","year":"2015","journal-title":"BMJ"},{"key":"2022050522132729400_zwab224-B22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/0141076816680121","article-title":"The definition of stroke","volume":"110","author":"Coupland","year":"2017","journal-title":"J R Soc Med"},{"key":"2022050522132729400_zwab224-B23","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1161\/ATVBAHA.107.160408","article-title":"Vascular calcifications in homozygote familial hypercholesterolemia","volume":"28","author":"Awan","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022050522132729400_zwab224-B24","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1177\/2047487319829746","article-title":"Genetic testing for familial hypercholesterolemia: impact on diagnosis, treatment and cardiovascular risk","volume":"26","author":"Lee","year":"2019","journal-title":"Eur J Prev Cardiol"}],"container-title":["European Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/29\/5\/817\/43562866\/zwab224.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/29\/5\/817\/43562866\/zwab224.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T22:15:27Z","timestamp":1651788927000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjpc\/article\/29\/5\/817\/6484422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,27]]},"references-count":24,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,12,27]]},"published-print":{"date-parts":[[2022,5,5]]}},"URL":"https:\/\/doi.org\/10.1093\/eurjpc\/zwab224","relation":{},"ISSN":["2047-4873","2047-4881"],"issn-type":[{"value":"2047-4873","type":"print"},{"value":"2047-4881","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,3,1]]},"published":{"date-parts":[[2021,12,27]]}}}